Epigenomics announced that it has appointed its chief operating officer Uwe Staub to serve on the company's executive board. Staub has been with Epigenomics since 2008, and his portfolio has including product development, R&D, medical and regulatory affairs, customer support, and manufacturing. He also previously held posts at Abbott Diagnostics, Digene, and Qiagen.
People in the News: Uwe Staub
Apr 11, 2013